Abstract
BackgroundThe advent of immune checkpoint blockade antibodies has demonstrated that effective mobilization of T cell responses can cause tumor regression of metastatic cancers, although these responses are heterogeneous and restricted...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have